Drug recall · July 26, 2023
Tizanidine Tablets USP recall
Why: Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10
- Lots / codes
Lot: T2100585, T2100586, T2100587, Exp 12/2023
- Quantity
- 17,548 1000-countbottles
- Company
- Dr Reddy's Laboratories Limited, Ranasthalam Mandal, Srikakulam, N/A
- Distribution
- Nationwide in the USA
- Initiated
- June 21, 2023 · N/A
- Classified
- July 17, 2023
- Reported
- July 26, 2023
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tizanidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.